FAF
BMY icon

Första AP-fonden’s Bristol-Myers Squibb BMY Stock Holding History

Första AP-fonden’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-436,400
Closed -$23.5M – 70
2025
Q4 		$23.5M Sell
436,400
-7,100
-2% -$342K 0.14% 127
2025
Q3 		$20M Buy
443,500
+25,700
+6% +$1.2M 0.12% 156
2025
Q2 		$19.3M Sell
417,800
-43,800
-9% -$2.15M 0.13% 152
2025
Q1 		$28.2M Sell
461,600
-176,400
-28% -$10.3M 0.21% 87
2024
Q4 		$36.1M Sell
638,000
-11,800
-2% -$659K 0.26% 70
2024
Q3 		$33.6M Buy
649,800
+18,100
+3% +$849K 0.26% 72
2024
Q2 		$26.2M Buy
631,700
+83,300
+15% +$3.73M 0.23% 78
2024
Q1 		$29.7M Buy
548,400
+29,600
+6% +$1.51M 0.25% 77
2023
Q4 		$26.6M Sell
518,800
-56,100
-10% -$2.94M 0.27% 71
2023
Q3 		$33.4M Sell
574,900
-3,200
-0.6% -$196K 0.37% 48
2023
Q2 		$37M Sell
578,100
-24,900
-4% -$1.67M 0.4% 44
2023
Q1 		$41.8M Sell
603,000
-51,000
-8% -$3.6M 0.49% 36
2022
Q4 		$47.1M Buy
654,000
+90,300
+16% +$6.81M 0.53% 33
2022
Q3 		$40.1M Buy
563,700
+74,400
+15% +$5.4M 0.49% 39
2022
Q2 		$37.7M Sell
489,300
-10,100
-2% -$769K 0.49% 37
2022
Q1 		$36.5M Sell
499,400
-32,700
-6% -$2.2M 0.41% 47
2021
Q4 		$33.2M Sell
532,100
-18,600
-3% -$1.09M 0.33% 57
2021
Q3 		$32.6M Buy
550,700
+55,900
+11% +$3.68M 0.37% 52
2021
Q2 		$33.1M Buy
494,800
+48,900
+11% +$3.19M 0.39% 48
2021
Q1 		$28.1M Sell
445,900
-68,200
-13% -$4.24M 0.39% 45
2020
Q4 		$31.9M Buy
514,100
+84,800
+20% +$5.21M 0.48% 40
2020
Q3 		$25.9M Buy
429,300
+14,600
+4% +$879K 0.53% 38
2020
Q2 		$24.4M Buy
414,700
+72,300
+21% +$4.32M 0.64% 29
2020
Q1 		$19.1M Buy
+342,400
New +$20.9M 0.69% 24

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Första AP-fonden's BMY Position: Q1 2026 in Review

Första AP-fonden sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 436,400 shares — an estimated $23.5M sold.

Första AP-fonden first reported a position in BMY in Q1 2020 and held it in 24 quarters. The position peaked at $47.1M in Q4 2022. 2,543 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Första AP-fonden reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 436,400 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.5M.
  • Första AP-fonden first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's Bristol-Myers Squibb position peaked at $47.1M in Q4 2022.
  • 2,543 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.